Which medication and dose are listed for pediatric nausea/vomiting with maximum dosing specified?

Which medication and dose are listed for pediatric nausea/vomiting with maximum dosing specified?

• A. Ondansetron 0.15 mg/kg ODT/IM/IV/IO; max dose 4 mg
• B. Metoclopromide 5 mg slow IV/IO bolus over 1-2 mins or IM
• C. Dimenhydrinate 1 mg/kg
• D. Promethazine 0.5 mg/kg

Answer: (A)

For pediatric nausea and vomiting, using a weight-based dose that also has a clearly defined maximum helps ensure effectiveness while preventing overdose in small children. The ondansetron option fits this approach: a dose of 0.15 mg/kg with a maximum cap of 4 mg, and it can be given via multiple routes (ODT, IM, IV, IO), which is practical in kids who may not tolerate certain administrations. The explicit max dose provides a safety check that the other options don’t offer in the listed format. The other medications listed either present fixed doses without a specified maximum, or carry safety concerns in pediatrics (for example, promethazine has notable risks in children, and metoclopramide dosing in the pediatric setting is often more limited by safety considerations). Dimenhydrinate dosing is given as a weight-based amount but without a stated maximum in the item, so it doesn’t meet the same clearly defined maximum criterion as ondansetron.

For pediatric nausea and vomiting, using a weight-based dose that also has a clearly defined maximum helps ensure effectiveness while preventing overdose in small children. The ondansetron option fits this approach: a dose of 0.15 mg/kg with a maximum cap of 4 mg, and it can be given via multiple routes (ODT, IM, IV, IO), which is practical in kids who may not tolerate certain administrations. The explicit max dose provides a safety check that the other options don’t offer in the listed format.

The other medications listed either present fixed doses without a specified maximum, or carry safety concerns in pediatrics (for example, promethazine has notable risks in children, and metoclopramide dosing in the pediatric setting is often more limited by safety considerations). Dimenhydrinate dosing is given as a weight-based amount but without a stated maximum in the item, so it doesn’t meet the same clearly defined maximum criterion as ondansetron.